» Authors » Christine Villatte

Christine Villatte

Explore the profile of Christine Villatte including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 41
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Voute M, Morel V, Joly D, Villatte C, Martin E, Durando X, et al.
J Clin Med . 2020 Jun; 9(6). PMID: 32570868
The impact of psychosocial vulnerability on pain in the year following breast cancer diagnosis has been little studied. To identify a score of psychosocial vulnerability (cognitive, emotional, quality of life...
2.
Molin Y, Gallay C, Gautier J, Lardy-Cleaud A, Mayet R, Grach M, et al.
Cancer Med . 2019 May; 8(6):2950-2961. PMID: 31055887
Purpose: The identification and referral of patients in need of palliative care should be improved. The French society for palliative support and care recommended to use the PALLIA-10 questionnaire and...
3.
Morel V, Joly D, Villatte C, Pereira B, Pickering G
BMJ Open . 2018 Oct; 8(9):e017986. PMID: 30287600
Introduction: Breast cancer affects 1 in 10 women worldwide, and mastectomy is a cause of chronic pain with neuropathic characteristics. -methyl-D-aspartate receptor (NMDAR) antagonists such as ketamine, memantine, dextromethorphan or...
4.
Morel V, Joly D, Villatte C, Dubray C, Durando X, Daulhac L, et al.
PLoS One . 2016 Apr; 11(4):e0152741. PMID: 27050431
Background: Neuropathic pain following surgical treatment for breast cancer with or without chemotherapy is a clinical burden and patients frequently report cognitive, emotional and quality of life impairment. A preclinical...
5.
Martin E, Morel V, Joly D, Villatte C, Delage N, Dubray C, et al.
Contemp Clin Trials . 2015 Feb; 41:146-51. PMID: 25636304
Background: Anti-cancer chemotherapy often induces peripheral neuropathy and consequent cognitive and quality of life impairment. Guidelines recommend antiepileptics or antidepressants but their efficacy is limited.Dextromethorphan, a N-methyl-D-aspartate receptor antagonist, has...
6.
Pickering G, Morel V, Joly D, Villatte C, Roux D, Dubray C, et al.
Trials . 2014 Aug; 15:331. PMID: 25142039
Background: N-methyl-D-aspartate receptor antagonists are potential therapies for neuropathic pain, and memantine has a good tolerance profile. A preclinical study recently reported that presurgery memantine may prevent neuropathic pain development...